Article 26 Sep 2022 The CCPA's Lasting Impact On U.S. Patent Law - An Examination Of CCPA Written Description Decisions United States IP
Article 10 May 2022 Claim Components Without Amount Or Function Limitations Anticipated By Bare Disclosure United States IP
Article 14 Mar 2022 ANDA Specification Controls Infringement Analysis, Not Expert Testimony United States IP
Article 20 Jan 2022 "Show More Of You": Amgen V. Sandoz, Battling It Out On Amgen's Otezla® Drug United States IP
Article 18 Nov 2021 A Mixed Bag: Some Claims Found Unpatentable But Others Are Patentable United States IP